Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial. [electronic resource]
Producer: 20150615Description: 297-302 p. digitalISSN:- 1465-3664
- Amikacin -- therapeutic use
- Anti-Bacterial Agents -- therapeutic use
- Bacterial Infections -- drug therapy
- Drug Therapy, Combination
- Female
- Gram-Negative Bacteria -- drug effects
- Gram-Positive Bacteria -- drug effects
- Humans
- India
- Infant, Newborn
- Male
- Penicillanic Acid -- analogs & derivatives
- Piperacillin
- Piperacillin, Tazobactam Drug Combination
- Risk Factors
- Sepsis -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.